Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

880 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review.
von Hardenberg J, Schwartz M, Werner T, Fuxius S, Strauss A, Worst TS, Nuhn P, Bolenz C, Heinrich E. von Hardenberg J, et al. Among authors: werner t. Urol Int. 2017;99(4):414-421. doi: 10.1159/000477943. Epub 2017 Jul 13. Urol Int. 2017. PMID: 28700990 Review.
Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial.
Grimm MO, Schostak M, Grün CB, Loidl W, Pichler M, Zimmermann U, Schmitz-Dräger B, Steiner T, Roghmann F, Niegisch G, Bolenz C, Schmitz M, Baretton G, Leucht K, Schumacher U, Foller S, Zengerling F, Meran J; TITAN-TCC Study Group. Grimm MO, et al. JAMA Oncol. 2024 Jun 1;10(6):755-764. doi: 10.1001/jamaoncol.2024.0938. JAMA Oncol. 2024. PMID: 38722641 Clinical Trial.
Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study.
Jakob A, Zahn MO, Nusch A, Werner T, Schnell R, Frank M, Hamm N, Däßler KU, Losem C, Welslau M, Hoevel P, Potthoff K. Jakob A, et al. Among authors: werner t. J Bone Oncol. 2022 Mar 3;33:100420. doi: 10.1016/j.jbo.2022.100420. eCollection 2022 Apr. J Bone Oncol. 2022. PMID: 35340302 Free PMC article.
PET, SPECT, and MRI imaging for evaluation of Parkinson's disease.
Gujral J, Gandhi OH, Singh SB, Ahmed M, Ayubcha C, Werner TJ, Revheim ME, Alavi A. Gujral J, et al. Among authors: werner tj. Am J Nucl Med Mol Imaging. 2024 Dec 15;14(6):371-390. doi: 10.62347/AICM8774. eCollection 2024. Am J Nucl Med Mol Imaging. 2024. PMID: 39840378 Free PMC article. Review.
Histamine H3 receptor blockade alleviates neuropathic pain through the regulation of glial cells activation.
Degutis M, Łażewska D, Barut J, Białoń M, Latacz G, Szczepańska K, Pietruś W, Werner T, Karcz T, Stark H, Kreiner G, Kieć-Kononowicz K, Starowicz K, Popiolek-Barczyk K. Degutis M, et al. Among authors: werner t. Biomed Pharmacother. 2025 Jan 15;183:117850. doi: 10.1016/j.biopha.2025.117850. Online ahead of print. Biomed Pharmacother. 2025. PMID: 39818100 Free article.
Phenotype-Led Identification of IL-10 Upregulators in Human CD4+ T-cells and Elucidation of Their Pharmacology as Highly Selective CDK8/CDK19 Inhibitors.
Nicolle S, Barker M, Barrett J, Campbell M, Wojno-Picon J, Atkinson SJ, Aylott H, Kessedjian H, He Y, Messenger C, Roberts E, Spitzfaden C, Le J, Zinn N, Werner T, Dümpelfeld B, Bantscheff M, Somers DO, Reid H, Thang K, Gobbetti T, Lewis HD. Nicolle S, et al. Among authors: werner t. J Med Chem. 2025 Jan 8. doi: 10.1021/acs.jmedchem.4c02630. Online ahead of print. J Med Chem. 2025. PMID: 39780505
880 results